To our surprise, the m6A.cluster1 was remarkably rich in CD4+ T cells, NK cells, and dendritic cells (Figure 3C), responsible for antigen presentation and the activation of naive T cells [24,27], indicating that the m6A.cluster1 has an anti-tumor immune status. The gene discussed is CD4; the disease is neoplasm.